JCM
VRTX icon

Jag Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Jag Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,674
Closed -$6.55M – 149
2024
Q1 		$6.55M Sell
15,674
-13,736
-47% -$5.81M 0.93% 34
2023
Q4 		$12M Sell
29,410
-12,776
-30% -$4.72M 1.83% 22
2023
Q3 		$14.7M Sell
42,186
-579
-1% -$202K 1.77% 20
2023
Q2 		$15M Sell
42,765
-698
-2% -$235K 1.74% 20
2023
Q1 		$13.7M Sell
43,463
-588
-1% -$176K 1.77% 19
2022
Q4 		$12.7M Sell
44,051
-2,037
-4% -$621K 1.84% 20
2022
Q3 		$13.3M Buy
46,088
+6,159
+15% +$1.77M 1.86% 17
2022
Q2 		$11.3M Buy
39,929
+36,199
+970% +$9.69M 1.39% 26
2022
Q1 		$802K Buy
+3,730
New +$885K 0.08% 122
2021
Q3 		– Sell
-3,730
Closed -$752K – 240
2021
Q2 		$752K Hold
3,730
– – 0.06% 137
2021
Q1 		$802K Sell
3,730
-4,215
-53% -$926K 0.07% 127
2020
Q4 		$1.88M Sell
7,945
-58,263
-88% -$13.4M 0.17% 85
2020
Q3 		$18M Sell
66,208
-625
-0.9% -$172K 1.86% 22
2020
Q2 		$19.4M Buy
66,833
+2,405
+4% +$652K 2.27% 16
2020
Q1 		$15.3M Buy
64,428
+39,654
+160% +$9.1M 2.26% 16
2019
Q4 		$5.42M Buy
+24,774
New +$5.01M 0.62% 40
2019
Q2 		– Sell
-53,003
Closed -$9.75M – 199
2019
Q1 		$9.75M Buy
53,003
+4,397
+9% +$812K 1.59% 29
2018
Q4 		$8.05M Buy
+48,606
New +$8.42M 1.64% 30
2018
Q3 		– Sell
-17,695
Closed -$3.01M – 105
2018
Q2 		$3.01M Sell
17,695
-43,560
-71% -$6.75M 0.52% 35
2018
Q1 		$9.98M Buy
+61,255
New +$10M 1.85% 27
2017
Q4 		– Sell
-33,583
Closed -$5.11M – 113
2017
Q3 		$5.11M Buy
+33,583
New +$5.05M 0.96% 36

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Jag Capital Management's VRTX Position: Q2 2024 in Review

Jag Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2024, closing a stake of 15,674 shares — an estimated $6.55M sold.

Jag Capital Management first reported a position in VRTX in Q3 2017 and held it in 21 quarters. The position peaked at $19.4M in Q2 2020. 1,547 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

  • Jag Capital Management reported no remaining Vertex Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Jag Capital Management sold 15,674 Vertex Pharmaceuticals shares in Q2 2024, an estimated $6.55M.
  • Jag Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2017 and held it in 21 quarters.
  • Jag Capital Management's Vertex Pharmaceuticals position peaked at $19.4M in Q2 2020.
  • 1,547 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on Jag Capital Management's 13F filing for Q2 2024, filed 30 Jul 2024.